Early Life Intervention in Pediatrics Supported by E-health - SMOKE
ELIPSE-II
1 other identifier
interventional
160
1 country
1
Brief Summary
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 15, 2024
CompletedStudy Start
First participant enrolled
May 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
May 6, 2026
April 1, 2026
3.7 years
March 7, 2024
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in urinary levels of cotinine in children
Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine
At 22 weeks after baseline (Post intervention)
Change from baseline in urinary levels of cotinine in children
Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine
At 48 weeks after baseline (Follow-Up)
Secondary Outcomes (1)
Change from baseline in protective measures taken by parents to protect children from second-hand smoke exposure
During intervention (week 2-22), post intervention (week 22-23) and follow-up (week 48-49)
Other Outcomes (8)
Acceptance and usability of the app (parent reported outcome)
At 22 weeks after baseline (Post intervention)
Acceptance of the app
During the intervention (week 2-22)
Usability of the app
During the intervention (week 2-22)
- +5 more other outcomes
Study Arms (2)
Treatment group (Life-style app)
EXPERIMENTALParents receive a smartphone app during the main intervention period of 20 weeks. The app (life-style app) aims to promote healthy behaviour through cognitive-behavioural impact factors.
Control group
SHAM COMPARATORThe parents get an information sheet with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.
Interventions
The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.
The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.
Eligibility Criteria
You may qualify if:
- Age: younger than 6 years
- Exposed to second-hand smoke at home (at least one parent smoking)
- German speaking parent
- All sex and ethnic backgrounds
- Signed informed consent form from parent
- Children live/grow-up in the same household as the parental participant
- Referred by a health care professional (e.g. physician, midwife, nurse, other professions)
You may not qualify if:
- Participation in another study/trial targeting similar outcomes
- Participation in an active smoking cessation programme
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Insel Gruppe AG, University Hospital Bernlead
- University of Berncollaborator
Study Sites (1)
Department of Paediatrics, Inselspital, Bern University Hospital
Bern, 3010, Switzerland
Related Publications (1)
Koch A, Wyssen A, Haupt C, Hammelbeck J, van Dorland HA, Fluck CE, Latzin P, Saner C, Jakob J, Kaess M, Kopp MV. Early Life Intervention in Paediatrics Supported by E-Health (ELIPSE)-a coaching app for parents to reduce obesity and second-hand smoke exposure in children: study protocols for two parallel-group randomised controlled trials. Trials. 2025 Nov 18;26(1):520. doi: 10.1186/s13063-025-09251-5.
PMID: 41254719DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias V. Kopp, Prof. Dr.
Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland
- PRINCIPAL INVESTIGATOR
Michael Kaess, Prof. Dr.
Universitäre Psychiatrische Dienste Bern (UPD), University of Bern, Switzerland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- The study team members who are conducting assessments on the participants remain blinded to the treatment allocation.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 15, 2024
Study Start
May 7, 2024
Primary Completion (Estimated)
January 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share